Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the U.S. due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. The issue was identified during an investigation of crystallization in a different lot of Sandimmune Oral Solution 100 mg/mL. No other Sandimmune formulations are impacted. Sandimmune Oral Solution 100 mg/mL, packag...